Published : 2025-06-23

Impact of Filling Process Interruptions on m-Cresol Concentration in Parenteral Drug Formulations

Renata Sobieska-Żołądkiewicz

Małgorzata Ulanowicz

Radoslaw Gladysz

Marek Mularewicz

Abstract

Ensuring the appropriate concentration of antimicrobial preservatives in multi-dose sterile pharmaceutical formulations is critical for maintaining sterility, quality, and stability throughout the product’s shelf life. However, preservatives such as m-cresol and phenol are known to adsorb onto silicone components used during manufacturing, leading to potential preservative loss. This study investigates the impact of manufacturing process stops, particularly during the filling stage, on m-cresol concentration in dosed cartridges. Laboratory-scale experiments and full-scale manufacturing studies were conducted using solutions containing recombinant human insulin (RHI), insulin lispro, and a placebo solution to evaluate the effects of interruptions in the filling process—such as internal process control (IPC) checks—on the adsorption of m-cresol from pharmaceutical formulations.

Keywords:

preservative, insulin, filling process, parenteral formulation, m-cresol


Similar Articles

1 2 3 > >> 

You may also start an advanced similarity search for this article.


Details

References

Statistics

Authors

Download files

PDF

Citation rules

Sobieska-Żołądkiewicz, R., Ulanowicz, M., Gladysz, R., & Mularewicz, M. (2025). Impact of Filling Process Interruptions on m-Cresol Concentration in Parenteral Drug Formulations. Prospects in Pharmaceutical Sciences, 23(2), 96–100. https://doi.org/10.56782/pps.391

Altmetric indicators


Cited by / Share


Licence


Editorial Team
Stefana Banacha 1
02-097 Warsaw, Poland
biuletynfarmacji@wum.edu.pl
Publisher:
Medical University of Warsaw
ul. Żwirki i Wigury 61
02-091 Warszawa

About:
Copyright 2021 by
OJS Support and Customization by LIBCOM
Platform & workfow by OJS/PKP